Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: Activation of the p38 MAP kinase signal pathway

Oncogene

Volumn 22, Issue 41, 2003, Pages 6377-6386

  Holmes, William F ^a   Soprano, Dianne Robert ^a   Soprano, Kenneth J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CD437; MAP kinase; MEF 2; Retinoids; TR3

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CASPASE 3; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; ANTINEOPLASTIC AGENT; MAP3K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ORPHAN NUCLEAR RECEPTOR TR3; PROTEIN SERINE THREONINE KINASE; RETINOID; STEROID RECEPTOR; THYROID HORMONE RECEPTOR;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CARCINOMA CELL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DEPOLARIZATION; DOWN REGULATION; DRUG INHIBITION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; ANIMAL; CARCINOMA; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; METABOLISM; OVARY TUMOR; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; ENZYME ACTIVATION; FEMALE; HUMANS; MAP KINASE KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; RETINOIDS; SIGNAL TRANSDUCTION;

EID: 0142135505     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206694     Document Type: Article

References (56)

1. Adachi H, Adams A, Hughes FM, Zhang J, Cidlowski JA and Jetten AM. (1998). Cell Death Differ., 5, 973-983.
2. Appierto V, Cavadini E, Pergolizzi R, Cleris L, Lotan R, Canevari S and Formelli F. (2001). Br. J. Cancer, 84, 1528-1534.
3. Assefa Z, Vantieghem A, Garmyn M, Declercq W, Vandenabeele P, Vandenheede JR, Bouillon R, Merlevede W and Agostinis P. (2000). J. Biol Chem., 275, 21416-21421.
4. Bild AH, Mendoza FJ, Gibson EM, Huang M, Villanueva J, Garrington TP, Jove R, Johnson GL and Gibson SB. (2002). Oncogene, 21, 6649-6656.
5. Chao WR, Hobbs PD, Jong L, Zhang XK, Zheng Y, Wu Q, Shroot B and Dawson ML (1997). Cancer Lett., 115, 1-7.
6. Davvson MI, Hobbs PD, Peterson VJ, Leid M, Lange CW, Feng KC, Chen G, Gu J, Li H, Kolluri SK, Zhang X, Zhang Y and Fontana JA. (2001). Cancer Res., 61, 4723-4730.
7. De Luca LM. (1991). FASEB J., 5, 2924-2933.
8. Gibson SB, Oyer R, Spalding AC, Anderson SM and Johnson GL. (2000). Mol. Cell. Biol., 20, 205-212.
9. Gudas L, Sporn M and Roberts A. (1994). The Retinoids, 2nd ed. Sporn MB, Roberts AB, Goodman DS (eds). Raven Press: New York, pp. 443-520.
10. Han J and Molkentin JD. (2000). Trends Cardiovasc. Med., 10, 19-22.
11. Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K, Kuida K, Yonehara S, Ichijo H and Takeda K. (2000). J. Biol. Chem., 275, 26576-26581.
12. Holmes WF, Dawson MI, Soprano DR and Soprano KJ. (2000). J. Cell. Physiol., 185, 61-67.
13. Holmes WF, Soprano DR and Soprano KJ. (2002). J. Biol. Chem., 277, 45408-45419.
14. Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC and Fontana JA. (1997). Blood, 89, 4470-4479.
15. Kasler HG, Victoria J, Duramad O and Winoto A. (2000). Mol. Cell. Biol., 20, 8382-8389.
16. Kastner P, Mark M and Chambon P. (1995). Cell, 83, 859-869.
17. Katagiri Y, Takeda K, Yu ZX, Ferrans VJ, Ozato K and Guroff G. (2000). Nat. Cell Biol., 2, 435-440.
18. Kumar A, Soprano DR and Parekh HK. (2001). Cancer Res., 61, 7552-7555.
19. Langdon SP, Rabiasz GJ, Ritchie AA, Reichert U, Buchan P, Miller WR and Smyth JF. (1998). Cancer Chemother. Pharmacol., 42, 429-432.
20. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC and Zhang X. (2000). Science, 289, 1159-1164.
21. Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D and Zhang XK. (1998). Mol. Cell Biol., 18, 4719-4731.
22. Liu S, Wu Q, Ye XF, Cai JH, Huang ZW and Su WJ. (2002). World J. Gastroenterol., 8, 446-450.
23. Liu W, Youn HD and Liu JO. (2001). Eur. J. Immunol., 31, 1757-1764.
24. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM and Osborne BA. (1994). Nature, 367, 281-284.
25. MacFarlane M, Cohen GM and Dickens M. (2000). Biochem. J., 348 (Part 1), 93-101.
26. Means AL and Gudas LJ. (1995). Annu. Rev. Biochem., 64, 201-233.
27. Moon R, Metha R and Rao K. (1994). The Retinoids, 2nd ed. Sporn MB, Roberts AB, Goodman DS (eds). Raven press: New York, pp. 573-596.
28. Okamoto S, Li Z, Ju C, Scholzke MN, Mathews E, Cui J, Salvesen GS, Bossy-Wetzel E and Lipton SA. (2002). Proc. Natl. Acad. Sci. USA, 99, 3974-3979.
29. Oridate N, Higuchi M, Suzuki S, Shroot B, Hong WK and Lotan R. (1997). Int. J. Cancer, 70, 484-487.
30. Piedrafita FJ and Pfahl M. (1997). Mol. Cell Biol., 17, 6348-6358.
31. Sakaue M, Adachi H, Dawson M and Jetten AM. (2001). Cell Death Differ., 8, 411-424.
32. Sanchez-Perez I, Benitah SA, Martinez-Gomariz M, Lacal JC and Perona R. (2002). Mol. Biol. Cell, 13, 2933-2945.
33. Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Stuting S, von Stebut E, Worm M, Makki A, Jurgovsky K, Kolde G and Henz BM. (1996). J. Cell Biol., 135, 1889-1898.
34. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11, 493-504.
35. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Chin WW and Eberlein TJ. (1997). J. Biol. Chem., 272, 18990-18999.
36. Sun SY, Yue P, Chandraratna RA, Tesfaigzi Y, Hong WK and Lotan R. (2000a). Mol. Pharmacol., 58, 508-514.
37. Sun SY, Yue P, Chen X, Hong WK and Lotan R. (2002). Cancer Res., 62, 2430-2436.
38. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK and Lotan R. (1997). Cancer Res., 57, 4931-4939.
39. Sun SY, Yue P, Hong WK and Lotan R. (2000b). Cancer Res., 60, 7149-7155.
40. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK and Lotan R. (1999). Cancer Res., 59, 2829-2833.
41. Szondy Z, Reichert U, Bernardon JM, Michel S, Toth R, Ancian P, Ajzner E and Fesus L. (1997). Mol. Pharmacol., 51, 972-982.
42. Widschwendter M, Daxenbichler G, Culig Z, Michel S, Zeimet AG, Mortl MG, Widschwendter A and Marth C. (1997). Int. J. Cancer, 71, 497-504.
43. Woronicz JD, Calnan B, Ngo V and Winoto A. (1994). Nature, 367, 277-281.
44. Wu S, Zhang D, Donigan A, Dawson MI, Soprano DR and Soprano KJ. (1998). J. Cell Biochem., 68, 378-388.
45. Yang SH, Galanis A and Sharrocks AD. (1999). Mol. Cell Biol., 19, 4028-4038.
46. Youn HD, Chatila TA and Liu JO. (2000). EMBO J., 19, 4323-4331.
47. Youn HD and Liu JO. (2000). Immunity, 13, 85-94.
48. Youn HD, Sun L, Prywes R and Liu JO. (1999). Science, 286, 790-793.
49. Zhang D, Holmes WF, Wu S, Soprano DR and Soprano KJ. (2000). J. Cell Physiol., 185, 1-20.
50. Zhang D, Vuocolo S, Masciullo V, Sava T, Giordano A, Soprano DR and Soprano KJ. (2001). Oncogene, 20, 7935-7944.
51. Zhang XK. (2002). Endocr. Relat. Cancer, 9, 87-102.
52. Zhang Y, Dawson MI, Mohammad R, Rishi AK, Farhana L, Feng KC, Leid M, Peterson V, Zhang XK, Edelstein M, Eilander D, Biggar S, Wall N, Reichert U and Fontana JA. (2002). Blood, 100, 2917-2925.
53. Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson M, Poirer G and Fontana JA. (1999). Exp. Cell Res., 247, 233-240.
54. Zhao M, Liu YW, Liu AH, Zhao KS and Jiang Y. (2000). Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, 32, 258-264.
55. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ and Han J. (1999). Mol. Cell Biol., 19, 21-30.
56. Zhuang S, Demirs JT and Kochevar IE. (2000). J. Biol. Chem., 275, 25939-25948.